Exploration of potential roles of a new LOXL2 splicing variant using network knowledge in esophageal squamous cell carcinoma

6Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

LOXL2 (lysyl oxidase-like 2), an enzyme that catalyzes oxidative deamination of lysine residue, is upregulated in esophageal squamous cell carcinoma (ESCC). A LOXL2 splice variant LOXL2-e13 and its wild type were overexpressed in ESCC cells followed by microarray analyses. In this study, we explored the potential role and molecular mechanism of LOXL2-e13 based on known protein-protein interactions (PPIs), following microarray analysis of KYSE150 ESCC cells overexpressing a LOXL2 splice variant, denoted by LOXL2-e13, or its wild-type counterpart. The differentially expressed genes (DEGs) of LOXL2-WT and LOXL2-e13 were applied to generate individual PPI subnetworks in which hundreds of DEGs interacted with thousands of other proteins. These two DEG groups were annotated by Functional Annotation Chart analysis in the DAVID bioinformatics database and compared. These results found many specific annotations indicating the potential specific role or mechanism for LOXL2-e13. The DEGs of LOXL2-e13, comparing to its wild type, were prioritized by the Random Walk with Restart algorithm. Several tumor-related genes such as ERO1L, ITGA3, and MAPK8 were found closest to LOXL2-e13. These results provide helpful information for subsequent experimental identification of the specific biological roles and molecular mechanisms of LOXL2-e13. Our study also provides a work flow to identify potential roles of splice variants with large scale data.

References Powered by Scopus

Global cancer statistics, 2002

17680Citations
N/AReaders
Get full text

Network biology: Understanding the cell's functional organization

6227Citations
N/AReaders
Get full text

Human Protein Reference Database - 2009 update

2687Citations
N/AReaders
Get full text

Cited by Powered by Scopus

LOXL2 in cancer: regulation, downstream effectors and novel roles

66Citations
N/AReaders
Get full text

Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy

61Citations
N/AReaders
Get full text

A novel splice variant of LOXL2 promotes progression of human papillomavirus–negative head and neck squamous cell carcinoma

17Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Wu, B. L., Lv, G. Q., Zou, H. Y., Du, Z. P., Wu, J. Y., Zhang, P. X., … Li, E. M. (2014). Exploration of potential roles of a new LOXL2 splicing variant using network knowledge in esophageal squamous cell carcinoma. Scientific World Journal, 2014. https://doi.org/10.1155/2014/431792

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

45%

Researcher 5

45%

Professor / Associate Prof. 1

9%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 5

36%

Medicine and Dentistry 4

29%

Biochemistry, Genetics and Molecular Bi... 3

21%

Social Sciences 2

14%

Save time finding and organizing research with Mendeley

Sign up for free